Immunoprophylaxis of perinatal transmiss
โ
J. I. Esteban; J. Genesca; R. Esteban; J. M. Hernandez; G. Seijo; M. Buti; R. Mu
๐
Article
๐
1986
๐
John Wiley and Sons
๐
English
โ 686 KB
One hundred eleven newborn infants born of Spanish hepatitis B surface antigen (HBsAg) carrier mothers were consecutively assigned to one of three treatment groups. Group A was treated with three or four doses of hepatitis B immune globulin (HBIG) in one of three different schedules. Group B receive